Creso Pharma has expanded its distribution agreement with nutritional supplements company Route2 Pharm to enable its hemp-derived therapeutic products to be sold under the Cannaqiz and Cannadol brands in Ecuador.
The move gives the company access to the rapidly growing Latin American CBD market which is expected to grow to more than US$300 million by 2024.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
